COP vs MGNX · P/E 19, rev $58.94B vs rev $149.5M
ConocoPhillips (COP) versus MacroGenics Inc (MGNX) — a side-by-side from cached financials, not a winner call.
ConocoPhillips (COP) is a oil & gas e&p company listed on NYSE. It is led by Ryan Lance.
MacroGenics Inc (MGNX) is a biotechnology company listed on NASDAQ.
Latest reported COP revenue for 2025-12-31 was $58.94B. Net income was $7.99B. Revenue was up 7.7% from 2024-12-31 to 2025-12-31. COP currently screens at market cap $135.49B and trailing P/E 18.8.
Latest reported MGNX revenue for 2025-12-31 was $149.5M. Net income was -$74.6M. Revenue was down 0.3% from 2024-12-31 to 2025-12-31. MGNX currently screens at market cap $246.6M.
COP currently screens at market cap $135.49B and trailing P/E 18.8. MGNX currently screens at market cap $246.6M.
Not investment advice. Open the COP and MGNX stock pages for the full models.
Not investment advice.